Previous Article | Next Article ![]()
Journal of Virology, July 2000, p. 6511-6519, Vol. 74, No. 14
Department of Molecular Physiology and
Biophysics, Vanderbilt University School of Medicine, Nashville,
Tennessee 37232
Received 29 October 1999/Accepted 17 April 2000
Many viral genes contain core promoters with two basal control
elements, the TATA box and the pyrimidine-rich initiator (Inr). However, the molecular mechanisms involved in transcription initiation from composite core promoters (TATA+ Inr+)
containing Inr elements are unclear. The Rous sarcoma virus (RSV)
long terminal repeat (LTR) contains a transcriptionally potent
enhancer and core promoter composed of a TATA box and an Inr-like
sequence, termed the transcription start site core (TSSC). Previously
we demonstrated that the TSSC binds the multifunctional Inr-binding
protein YY1. Here we present evidence that the TSSC also binds the
multifunctional transcription factor TFII-I and that both TFII-I and
YY1 are required for RSV LTR transcriptional activity. Gel shift assays
using anti-TFII-I antibody show that TFII-I is present in a protein
complex that specifically binds to the TSSC. Mutations in the TSSC that
reduce TFII-I binding also reduce RSV LTR enhancer and promoter
activity. Transient-transfection assays demonstrate that TFII-I
transactivates the RSV LTR from ca. fourfold (basal) to ca. sevenfold
(enhanced) in both human and natural host cell lines. Importantly, the
activity of the TSSC element can be attributed to the binding activity
of TFII-I and the YY1 protein, since mutation of each of these binding
sites within the TSSC element abolishes all viral expression as
demonstrated by transient-transfection assays. Taken together, these
data demonstrate that expression of RSV viral mRNA is dependent on both
TFII-I and YY1.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Rous Sarcoma Virus Long Terminal Repeat
Promoter Is Regulated by TFII-I
*
Corresponding author. Mailing address: Department of
Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, 752 MRB II, Nashville, TN 37232. Phone: (615) 322-3224. Fax:
(615) 322-7236. E-mail:
Linda.Sealy{at}mcmail.vanderbilt.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»